As Founder and President of BioInformant, the first and only market research firm to specialize in the stem cell industry, Cade Hildreth, B.A., M.S., has tracked the stem cell industry since 2006 (approximately 15 years).
Because there are hematopoietic stem cells (HSCs) in cord blood and mesenchymal stem cells (MSCs) in cord tissue, this is an important market segment within the broader stem cell industry. Having a 15 year data set on which to base identification of cord blood market trends and make future market predictions is extremely valuable, because the cord blood market has changed substantially over the past few years, with consolidation and maturation becoming two major industry trends. Other important trends include diversification of stem cell storage services, pairing of cord blood with genetic testing services, the introduction of stem cell insurance products, and advances in technologies to support cord blood stem cell expansion entering Phase II clinical trials.
Cade was a Primary Author for the definitive market report on the industry, a 226-page “Global Cord Blood Banking Industry Report” published by BioInformant.com, as well as numerous other stem cell industry reports.
Cade participates in a wide range of industry events, recently chairing the cord blood industry’s largest event, the “Cord Blood and Perinatal Stem Cell Track” of Phacilitate Leaders World in Miami, FL, in January. Cade helps to organize the Perinatal Stem Cell Society Congress held in Salt Lake City, UT, each March, as well as chairs and presents at the AABB’s “International Cord Blood Symposium” in San Diego (ICBS). In total, our team attends dozens of industry events each year.
Cade has authored 1,000+ articles and interviewed hundreds of executives from across the stem cell and cord blood industries, making our firm the the world’s leading authority in this area. We have as clients of BioInformant most leading stem cell companies worldwide, including market leaders from across the U.S. and the world.
About Cade Hildreth
Cade Hildreth is the Founder and President of BioInformant Worldwide, LLC. Cade Hildreth attended Dartmouth College & Smith College for Undergraduate Studies in Biology and then acquired a Master’s Degree in Biochemistry and Molecular Biology with Specialization in Biotechnology from Georgetown University, where they were Valedictorian. Cade also studied Dental Medicine at the University of Pennsylvania.
With more than 15 years of experience, Cade is a media expert on stem cell market trends, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, AABB, and Vogue Magazine.
As the President/CEO of BioInformant, Cade has been tracking the stem cell industry since 2006 and has nearly 15 years of historical information and insights on which to make future projections. As a stem cell patient, Cade also understands the therapeutic use of stem cells.
Scheduling a BioInformant Consulting Session
To schedule a consultation with Cade, use the checkout below. We will email you to confirm your schedule and availability.
BioInformant consulting is priced at $597 for one hour or $397 for 30 minutes.
*If you would like to establish an ongoing consulting relationship with BioInformant, email us at [email protected].